ReviewNature nanotechnology2017
Reproducibility, sharing and progress in nanomaterial databases.
Review in Nature nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Lysosome-centered nanomedicine for cancer therapy: mechanisms, materials, and modalities.Journal of nanobiotechnology · 2026Review
- Machine Learning-Enhanced Nanoparticle Design for Precision Cancer Drug Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Designing nanotheranostics with machine learning.Nature nanotechnology · 2024Review
- Expanding the Horizons of Machine Learning in Nanomaterials to Chiral Nanostructures.Advanced materials (Deerfield Beach, Fla.) · 2024Review
- Machine Learning-Assisted Low-Dimensional Electrocatalysts Design for Hydrogen Evolution Reaction.Nano-micro letters · 2023Review
- Synthesizing controlled microstructures of porous media using generative adversarial networks and reinforcement learning.Scientific reports · 2022Article
- Nano-bio surface interactions, cellular internalisation in cancer cells and e-data portals of nanomaterials: A review.IET nanobiotechnology · 2021Review
- Bridging international approaches on nanoEHS.Nature nanotechnology · 2021Article
- Towards FAIR nanosafety data.Nature nanotechnology · 2021Article
- Reliable Surface Analysis Data of Nanomaterials in Support of Risk Assessment Based on Minimum Information Requirements.Nanomaterials (Basel, Switzerland) · 2021Article
- ASINA Project: Towards a Methodological Data-Driven Sustainable and Safe-by-Design Approach for the Development of Nanomaterials.Frontiers in bioengineering and biotechnology · 2021Article
- Nanomedicine of tyrosine kinase inhibitors.Theranostics · 2021Review
- Rigor and reproducibility in polymer nanoparticle synthesis and characterization.RSC advances · 2020Article
- Exploiting machine learning for end-to-end drug discovery and development.Nature materials · 2019Article
- How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.Nature biomedical engineering · 2018Article
- Reopening the dialogue.Nature nanotechnology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.